INNOVENT BIOLOGICS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 1801 for the last semiannual is 3.79 B HKD, and it's 23.92% higher compared to the previous semiannual. The net income of H2 23 is -960.16 M HKD.